Value-based payment models continue to evolve to include considerations for quality of care, cost, and population health through a set of evidence-based metrics. As this shift continues, pathologists are challenged to find quantitative ways to demonstrate their value in newer payment structures. In this CAPcast, we’ll be joined again by Diana Cardona MD, FCAP who will be teaching a course at CAP 21 on how Pathologists can demonstrate their impact on overall quality and cost through various quality measures to maximize reimbursement in these programs.